MHC class I transactivator NLRC5 in host immunity, cancer and beyond

Steven X. Cho,Saptha Vijayan,Ji‐Seung Yoo,Toshiyuki Watanabe,Ryota Ouda,Ning An,Koichi S. Kobayashi
DOI: https://doi.org/10.1111/imm.13235
2020-08-03
Immunology
Abstract:The presentation of antigenic peptides by major histocompatibility complex (MHC) class I and class II molecules are crucial for activation of the adaptive immune system. The nucleotide‐binding domain and leucine‐rich repeat receptor family member, CIITA and NLRC5 functions as the major transcriptional activator of MHC class II and class I gene expression, respectively. Since the identification of NLRC5 as the master regulator of MHC class I and class I related genes, there has been major advances in understanding the function of NLRC5 in infectious diseases and cancer. Here, we discuss the biological significance and mechanism of NLRC5‐dependent MHC class I expression.
immunology
What problem does this paper attempt to address?